Bethesda-based American Capital sells Wis. drug maker

American Capital Ltd., of Bethesda, a publicly traded private equity and global asset management firm focused on middle-market investments, said it sold its portfolio company, SPL Acquisition Corp., of Wenaukee, Wis., to a Chinese company, Shenzhen Hepalink Pharmaceutical Co. Ltd., for $291 million in debt and equity proceeds.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>


Scroll To Top